Equity offering disclosure · Biotech
Alzheon discloses $78.8 million in equity sales
Alzheon reported $78.8 million sold in an ongoing private equity offering.
Alzheon disclosed $78,797,184 in equity sales to three investors in a September 10 filing. The offering has a $500 million ceiling, with about $421.2 million still available.
The Massachusetts drug developer is advancing oral treatments for Alzheimer’s disease. The filing reports a first sale on August 26 and does not identify the investors.
Funding history
Equity offering disclosure · This round$78.8M